Donor-specific portal blood transfusion in intestinal transplantation: A prospective, preclinical large animal study

Transplantation

Volumn 66, Issue 2, 1998, Pages 164-169

  Gruessner, Rainer W G ^a,b   Nakhleh, Raouf E ^c   Harmon, James V ^a   Dunning, Michele ^a   Gruessner, Angelika C ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISOLONE; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; AUTOPSY; BLOOD TRANSFUSION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTESTINE GRAFT; INTESTINE RESECTION; MIXED LYMPHOCYTE CULTURE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; SWINE;

ANIMALS; BLOOD TRANSFUSION; CAUSE OF DEATH; GRAFT VS HOST DISEASE; INTESTINES; PORTAL SYSTEM; SURVIVAL RATE; SWINE; TACROLIMUS;

EID: 0032558157     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199807270-00004     Document Type: Article

References (29)

1. Opelz G, Senger DPS, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973; 5: 253.
2. Starzl TE, Demetris AJ, Murase N, et al. Cell migration, chimerism, and graft acceptance. Lancet 1992; 339: 1579.
3. Grant D on behalf of the International Intestinal Transplant Registry. Current results of intestinal transplantation. Lancet 1996; 347: 1801.
4. Gruessner RWG, Uckun FM, Pirenne J, et al. Recipient preconditioning and donor-specific bone marrow infusion in a pig model of total bowel transplantation. Transplantation 1997; 63: 12.
5. Pirenne J, Gruessner AC, Benedetti E, et al. Donor-specific unmodified bone marrow transfusion does not facilitate intestinal engraftment after bowel transplantation in a porcine model. Surgery 1997; 121: 79.
6. Nakhleh RE, Hakim NS, Gruessner AC, et al. Comparison of rejection between colon and small bowel after total bowel transplantation in a preclinical model. Transpl Int 1996; 9: S269.
7. Wolf YG, Dunaway DJ, Harmel RP. Small-bowel transplantation following portal venous injection of donor strain spleen cells. Transplant Proc 1990; 22: 2493.
8. Fecteau AH, Tchervenkov JI, Guttman FM, Takara T, Rosenmann E. Small bowel transplantation. Transplantation 1994; 58: 399.
9. Takara T, Tchervenkov JI, Guttman FM, Fecteau A, Rosenmann E. Intraportal donor-specific transfusion given 24 hours before small bowel transplantation with cyclosporine and FK 506. Transplant Proc 1994; 26: 1622.
10. Gorczynski RM, Chan Z, Chung S, et al. Prolongation of rat small bowel or renal allograft survival by pretransplant transfusion and/or by varying the route of allograft venous drainage. Transplantation 1994; 58: 816.
11. Todo S, Reyes J, Furukawa H, et al. Outcome analysis of 71 clinical intestinal transplantations. Ann Surg 1995; 222: 270.
12. Cantor HM, Dumont AE. Hepatic suppression of sensitization to antigen absorbed into the portal system. Nature 1967; 215: 744.
13. Fujiwara H, Qian JH, Satoh S, Kokudo S, Ikegami R, Hamaoka T. Studies on the induction of tolerance to alloantigens. II. The generation of serum factors able to transfer alloantigen-specific tolerance for delayed-type hypersensitivity by portal venous inoculation with allogeneic cells. J Immunol 1986; 136: 2763.
14. Kenick S, Lowry RP, Forbes RDC, Lisbona R. Prolonged cardiac allograft survival following portal venous inoculation of allogeneic cells: what is "hepatic tolerance"? Transplant Proc 1987; 19: 478.
15. Kenick S, Lisbona R, Marghesco D, Lowry RP. Prolonged cardiac allograft survival following portal venous inoculation of allogeneic cells: immunologically specific entrapment of allogeneic cells within the liver. Transplant Proc 1987; 19: 3057.
16. Qian JH, Hashimoto T, Fujiwara H, Hamaoka T. Studies on the induction of tolerance to alloantigens. I. The abrogation of potentials for delayed-type-hypersensitivity responses to alloantigens by portal venous inoculation with allogeneic cells. J Immunol 1985; 134: 3656.
17. Nakafusa Y, Terasaka R, Matsuo K, Konomi K, Flye MW. Advantages of donor-specific blood transfusion in the rat via the portal vein for renal transplantation. Am J Kidney Dis 1993; 21: 433.
18. Lowry RP, Kenick S, Lisbona R. Speculation on the pathogenesis of prolonged cardiac allograft survival following portal venous inoculation of allogeneic cells. Transplant Proc 1987; 19: 3451.
19. Sato K, Yabuki K, Haba T, Maekawa T. Role of Kupffer cells in the induction of tolerance after liver transplantation. J Surg Res 1996; 63: 433.
20. Callery MP, Kamei T, Flye MW. Kupffer cell blockade inhibits induction of tolerance by the portal venous route. Transplantation 1989; 47: 1092.
21. Callery MP, Mangino MJ, Flye MW. Arginine-specific suppression of mixed lymphocyte culture reactivity by Kupffer cells: a basis of portal venous tolerance. Transplantation 1991; 51: 1076.
22. Takara T, Tchervenkov JI, Guttman FM, Fecteau A. Kupffer cell inhibition with gadolinium abrogates the beneficial effect of intraportal vein donor-specific transfusion given 24 hours before small bowel transplantation. Surg Forum 1993; 44: 635.
23. Kamei T, Callery MP, Flye MW. Kupffer cell blockade prevents induction of portal venous tolerance in rat cardiac allograft transplantation. J Surg Res 1990; 48: 393.
24. Tchervenkov JI, Epstein MD, Alexander JW, Schroeder TJ. The effect of donor-specific blood transfusion, cyclosporine, and dietary prostaglandin precursors on rat cardiac allograft survival. II. Effectiveness of a 24-hour induction period with DST and CsA in inducing long-term graft survival. Transplantation 1989; 47: 177.
25. Yoshimura N, Hamashima T, Matsui S, Oka T. Prolongation of rat renal allograft survival by portal venous inoculation with donor lymphocytes. Transplant Proc 1989; 21: 3268.
26. Rao VK, Burris ED, Gruel SM, Sollinger HW, Burlingham WJ. Evidence that donor spleen cells administered through the portal vein prolong the survival of cardiac allografts in rats. Transplantation 1988; 45: 1145.
27. Yoshimura N, Matsui S, Hamashima T, Lee CJ, Ohsaka Y, Oka T. The effects of perioperative portal venous inoculation with donor lymphocytes on renal allograft survival in the rat. I. Specific prolongation of donor grafts and suppressor factor in the serum. Transplantation 1990; 49: 167.
28. Kamei T, Callery MP, Flye MW. Pretransplant portal venous administration of donor antigen and portal venous allograft drainage synergistically prolong rat cardiac allograft survival. Surgery 1990; 108: 415.
29. Sakagami K, Saito S, Fujiwara T, Uda M, Matsuno T, Orita K. Evidence that perioperative portal venous inoculation with ultraviolet-B irradiated donor spleen cells sensitizes the recipients in cadaveric kidney transplantation. Transplant Proc 1994; 26: 2048.